Illustration of semaglutide (blue, red and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured 3D structure across membrane). A G protein, part of the GLP-1 signalling cascade, is visible below the membrane (rounded multicoloured structure). Semaglutide is a GLP-1 receptor agonist, a type of drug that mimics the function of natural GLP-1 hormones. GLP-1 hormones are released in the gastrointestinal tract when we eat. They work by binding to GLP-1 receptors throughout the body and stimulating insulin secretion, inhibiting glucagon secretion, and slowing down gastric emptying. These effects all lower blood sugar levels, making semaglutide a treatment option for type 2 diabetes. Semaglutide is the active ingredient in Ozempic, a drug used to treat diabetes.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP29693938
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images: